It is a pharma limited liability partnership based in Miraj, Maharashtra, India, established in 2022.
2022 | Miraj, Maharashtra, India | ActivePrimevision Pharma Llp, a active limited liability partnership, was established on 01 February 2022 in Miraj, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: ABA-4515. Registered under ROC Roc Pune. It has total obligation of contribution of ₹2.00 Cr.
Its leadership includes Atul Shashikant Dhanavade (Designated Partner), Ashishkumar Ramchandra Kore (Designated Partner), Yogesh Veerabhadra Mirji (Designated Partner). Past directors included Veerbhadra Kushnappa Mirji, Sarthak Suresh Sankh. It holds ₹14.30 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at Plot No. 28; Flat No. 206; Nirmiti Tower, Near Dr. Sanjeev Kulkarni Hospital,, Miraj, Maharashtra, 416410.
ABA-4515
01 February 2022
₹2.00 Cr
Roc Pune
Active
Explore comprehensive insights into Primevision Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Shashikant Dhanavade | Designated Partner | 01 Feb 2022 | Current |
| Ashishkumar Ramchandra Kore | Designated Partner | 01 Feb 2022 | Current |
| Yogesh Veerabhadra Mirji | Designated Partner | 18 Mar 2022 | Current |
| Vijay Kallappa Magdum | Designated Partner | 18 Mar 2022 | Current |
| Rajendrakumar Bhagvant Dhanavade | Designated Partner | 18 Mar 2022 | Current |
| Chetan Suresh Sankh | Designated Partner | 18 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Partner | - | Past |
| Pramod Abcsdd | Partner | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Primevision Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Primevision Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹143,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2022 | Bank Of India | ₹14.30 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Primevision Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Primevision Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primevision Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Primevision Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.
Primevision Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
A charge with Bank Of India of Rs. 14.30 Cr registered on 08 Jul 2022 with Charge ID 100632630 was modified on 11 Dec 2023. was recorded as a recent event.
The activity A charge with Bank Of India amounted to Rs. 14.30 Cr with Charge ID 100632630 was registered on 08 Jul 2022. was completed.
Progress on Yogesh Veerabhadra Mirji was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
Vijay Kallappa Magdum was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
The LLPIN of Primevision Pharma Llp is ABA-4515.
Primevision Pharma Llp is headquartered at Plot No. 28; Flat No. 206; Nirmiti Tower, Near Dr. Sanjeev Kulkarni Hospital,, Miraj, Maharashtra, 416410.
Primevision Pharma Llp was incorporated on 01 February 2022.
The current directors of Primevision Pharma Llp are
The primary industry of Primevision Pharma Llp is Pharma.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX